PubRank

Shinsuke Kido

Author PubWeight™ 22.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood 2005 1.85
2 Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion. Blood 2004 1.78
3 Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin. Clin Cancer Res 2007 1.48
4 Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology 2002 1.40
5 Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood 2002 1.31
6 Transcriptional induction of FosB/DeltaFosB gene by mechanical stress in osteoblasts. J Biol Chem 2004 1.12
7 Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth. PLoS One 2010 1.11
8 Inorganic phosphate homeostasis in sodium-dependent phosphate cotransporter Npt2b⁺/⁻ mice. Am J Physiol Renal Physiol 2011 0.96
9 GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE). Blood 2009 0.93
10 Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1alpha and MIP-1beta production. J Bone Miner Metab 2008 0.91
11 Sodium-dependent phosphate cotransporters: lessons from gene knockout and mutation studies. J Pharm Sci 2011 0.86
12 Hepatectomy-related hypophosphatemia: a novel phosphaturic factor in the liver-kidney axis. J Am Soc Nephrol 2013 0.84
13 Regulation of osteoblast differentiation by interleukin-11 via AP-1 and Smad signaling. Endocr J 2011 0.83
14 c-Fos degradation by the ubiquitin-proteasome proteolytic pathway in osteoclast progenitors. Bone 2005 0.82
15 Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis. Clin Cancer Res 2005 0.79
16 Decreased AP-1 activity and interleukin-11 expression by bone marrow stromal cells may be associated with impaired bone formation in aged mice. J Bone Miner Res 2003 0.79
17 Fibroblast growth factor 23 mediates the phosphaturic actions of cadmium. J Med Invest 2010 0.78
18 Induction of endosomal/lysosomal pathways in differentiating osteoblasts as revealed by combined proteomic and transcriptomic analyses. FEBS Lett 2010 0.78
19 Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess. Endocrinology 2013 0.76
20 Processing and stability of type IIc sodium-dependent phosphate cotransporter mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria. Am J Physiol Cell Physiol 2011 0.76
21 Gene expression associated with an enriched environment after transient focal ischemia. Brain Res 2010 0.76
22 Reverse J-curve relation between diastolic blood pressure and severity of coronary artery lesion in hypertensive patients with angina pectoris. Hypertens Res 2002 0.76
23 Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib. Int J Hematol 2013 0.75
24 [The roles of intestinal and renal sodium dependent phosphate transporters in phosphate homeostasis]. Clin Calcium 2012 0.75
25 Relationship between sodium-dependent phosphate transporter (NaPi-IIc) function and cellular vacuole formation in opossum kidney cells. J Med Invest 2015 0.75
26 [Treatment for osteoporosis with decreased bone formation]. Clin Calcium 2003 0.75
27 Identification and functional analysis of a splice variant of mouse sodium-dependent phosphate transporter Npt2c. J Med Invest 2012 0.75
28 [Phosphate sensing and intestine]. Clin Calcium 2012 0.75
29 Renal artery stenosis emerged after angiotensin-converting enzyme inhibitor treatment for myocardial infarction: a case report. Angiology 2005 0.75
30 [Type A behavior pattern as a coronary risk factor]. Nihon Rinsho 2003 0.75
31 Unequal effects of renin-angiotensin system inhibitors in acute cardiac dysfunction induced by isoproterenol. Am J Physiol Heart Circ Physiol 2004 0.75